About the Company
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
5328
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $DXCM News
DexCom, Inc. (NASDAQ:DXCM) Q1 2024 Earnings Call Transcript
Q1 2024 Earnings Call April 25, 2024 DexCom, Inc. beats earnings expectations. Reported EPS is $0.32, expectations were $0.27 ...
DexCom, Inc. (DXCM) Is a Trending Stock: Facts to Know Before Betting on It
DexCom (DXCM) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
DexCom, Inc. DXCM is well poised for growth in the coming quarters, backed by its strong product portfolio. A robust ...
DexCom (NASDAQ: DXCM)
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes.
Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...
Dexcom Reports First Quarter 2024 Financial Results
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2024. First Quarter 2024 Financial Highligh ...
DexCom: Q1 Earnings Snapshot
(DXCM) on Thursday reported first-quarter net income of $146.4 million. On a per-share basis, the San Diego-based company said it had profit of 36 cents.
Decoding DexCom Inc (DXCM): A Strategic SWOT Insight
Robust Revenue Growth: DexCom Inc ( NASDAQ:DXCM) reports a 24% increase in revenue year-over-year. Significant Net Income ...
DexCom Inc (DXCM) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
Warning! GuruFocus has detected 3 Warning Sign with DXCM. DexCom Inc (NASDAQ:DXCM) released its 8-K filing on April 25, 2024, ...
DexCom, Inc. (DXCM) Q1 2024 Earnings Call Transcript
Ladies and gentlemen, welcome to the Dexcom First Quarter 2024 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call. At this time, all participants are ...
Loading the latest forecasts...